Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 26 for your search:
Cancer Type/Condition:
Esophageal cancer
Stage/Subtype:
stage II esophageal cancer
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.
Phase:
Phase IV
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
16-00017
, NCT00754468
2.
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
RTOG-0436
, RTOG 0436, NCT00655876
3.
A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 to 85
Sponsor:
Other
Protocol IDs:
0806009855
, NCT00760604
4.
Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 to 82
Sponsor:
Other
Protocol IDs:
Pro00002207
, SPS 151596, NCT00578071
5.
Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
07326
, NCT00667420
6.
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CALGB-80302
, NCT00316862
7.
Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-06013
, NCT00354679
8.
Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Esophageal Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
RPCI-I-64105
, NCT00470184, I 64105
9.
Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 to 80
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
JHOC-J0386
, J0386, JHOC-04-02-20-03, ZENECA-IRUSIRES0304, NCT00493025
10.
Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Over 65
Sponsor:
NCI
Protocol IDs:
RPCI-I-62705
, I 62705, NCT00524121
11.
Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
BrUOG-E-215
, NCT00522795
12.
Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and GEJ
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
75 and under
Sponsor:
Other
Protocol IDs:
2003-0769
, NCT00525785
13.
Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 to 75
Sponsor:
Other
Protocol IDs:
2004-0703
, NCT00525915
14.
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
PR016-CLN-pro003
, NCT00573131
15.
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Locoregionally Advanced Cancer of the Esophagus, Gastroesophageal Junction, or Stomach
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
CASE-2Y07
, CASE2Y07, NCT00601705
16.
Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
ACOSOG-Z4051
, Z4051, NCT00757172
17.
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI, Other
Protocol IDs:
1399-05
, CA111603-01A1, NCT00217087
18.
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
DMS-9939
, NCI-G01-1931, NCT00014417
19.
Randomized, Double Blind, Placebo-Controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
NYU 05-409
, NCT00821652
20.
Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
40 to 79
Sponsor:
NCI
Protocol IDs:
NU-NWU08-11-01
, NWU08-11-01, NCI-08-11-01, RPCI-I-121507, NCT01013831
21.
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
Phase:
No phase specified
Type:
Supportive care, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
99-0522
, NCT00260559
22.
Chemoradiation-Induced Nausea and Emesis: Quality of Life
Phase:
No phase specified
Type:
Natural history/Epidemiology, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
2003-0529
, NCT00394602
23.
Trial of Preoperative Capecitabine Oxaliplatin Cetuximab & Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
NCT00060011
, NCT00430027
24.
IMRT Tomotherapy for Esophagus Cancer
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
06-1070
, NCT00593723
25.
The Effect of Ablation Therapy on Barrett's Esophagus
Phase:
No phase specified
Type:
Tissue collection/Repository, Treatment
Status:
Active
Age:
18 to 90
Sponsor:
Other
Protocol IDs:
258-04
, NCT00587314
Select All on Page
1
Help with Results
